These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8336623)

  • 1. Indications for use of intravenous immunoglobulin. Recommendations of the Australasian Society of Blood Transfusion consensus symposium.
    Keller T; McGrath K; Newland A; Gatenby P; Cobcroft R; Gibson J
    Med J Aust; 1993 Aug; 159(3):204-6. PubMed ID: 8336623
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy.
    Stein LD; Roifman CM
    Bull Rheum Dis; 1995 Jun; 44(4):3-5. PubMed ID: 7787963
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances in the pathophysiology of primary immune deficiencies and immunoglobulin therapy in HIV infection and autoimmune/inflammatory neurological disorders. Symposium proceedings. Indian Wells, California, January 24-25, 1992.
    Pediatr Res; 1993 Jan; 33(1 Suppl):S1-100. PubMed ID: 8094549
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic and topical immunoglobulin treatment in immunocompromised patients.
    Hammarström L; Gardulf A; Hammarström V; Janson A; Lindberg K; Smith CI
    Immunol Rev; 1994 Jun; 139():43-70. PubMed ID: 7523279
    [No Abstract]   [Full Text] [Related]  

  • 5. Established and new uses of intravenous immunoglobulin.
    Cunningham-Rundles C
    Mt Sinai J Med; 1992 Sep; 59(4):335-40. PubMed ID: 1406751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New uses for IVIgG immunoglobulin therapies.
    Wallington T
    Vox Sang; 2004 Jul; 87 Suppl 2():155-7. PubMed ID: 15209904
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous immunoglobulins in hematologic therapy].
    Giovanelli E
    Clin Ter; 1992 Sep; 141(9 Pt 2):69-73. PubMed ID: 1468201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies].
    Mouthon L; Bussone G; Kaveri S
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The indications for intravenous immunoglobulins in pediatric practice].
    Popescu V; Bleahu D
    Pediatrie (Bucur); 1992; 41(1):37-45. PubMed ID: 1322724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoglobulins--merely expensive or also useful?].
    Paar WD
    Ther Umsch; 1995 Oct; 52(10):639-44. PubMed ID: 7482374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
    Orange JS; Hossny EM; Weiler CR; Ballow M; Berger M; Bonilla FA; Buckley R; Chinen J; El-Gamal Y; Mazer BD; Nelson RP; Patel DD; Secord E; Sorensen RU; Wasserman RL; Cunningham-Rundles C;
    J Allergy Clin Immunol; 2006 Apr; 117(4 Suppl):S525-53. PubMed ID: 16580469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin therapy: indications, potential side effects, and treatment guidelines.
    Suez D
    J Intraven Nurs; 1995; 18(4):178-90. PubMed ID: 7629638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin: more questions than answers.
    Blanchette VS; Sacher RA
    Transfus Med Rev; 1991 Jul; 5(3):165-70. PubMed ID: 1821177
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of IVIgG treatment on fetal platelet count, HPA-1a titre and clinical outcome in a case of feto-maternal alloimmune thrombocytopenia.
    Lucas GF; Hamon M; Carroll S; Soothill P
    BJOG; 2002 Oct; 109(10):1195-8. PubMed ID: 12387480
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indications for intravenous immunoglobulins].
    Spertini F
    Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on the use of immunoglobulin in human disease: A review of evidence.
    Perez EE; Orange JS; Bonilla F; Chinen J; Chinn IK; Dorsey M; El-Gamal Y; Harville TO; Hossny E; Mazer B; Nelson R; Secord E; Jordan SC; Stiehm ER; Vo AA; Ballow M
    J Allergy Clin Immunol; 2017 Mar; 139(3S):S1-S46. PubMed ID: 28041678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supply, use, and abuse of intravenous immunoglobulin.
    Nowak-Wegrzyn A; Lederman HM
    Curr Opin Pediatr; 1999 Dec; 11(6):533-9. PubMed ID: 10590912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prioritization of evidence-based indications for intravenous immunoglobulin.
    Orange JS; Ochs HD; Cunningham-Rundles C
    J Clin Immunol; 2013 Aug; 33(6):1033-6. PubMed ID: 23764872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.